BridgeBio Pharma (BBIO) Non-Current Assets (2018 - 2026)
BridgeBio Pharma (BBIO) reported Non-Current Assets of $124.16 million for Q2 2026, down 26.1% from $167.91 million a year earlier and down 4.3% from the prior quarter.
BridgeBio Pharma (BBIO) Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma posted Non-Current Assets of $138.28 million, down 30.4% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $198.65 million in FY2024 (+188.8%), $68.79 million in FY2023 (-7.3%), $74.18 million in FY2022 (-40.1%) and $123.93 million in FY2021 (+104.0%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q1 2024.
- Year over year, Non-Current Assets has now declined in each of the last five quarters, with growth averaging 59.8% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q3 2021 (growth of 235.2%); the low point was Q2 2022 (a decline of 47.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $129.68 million (Q1 2026), $138.28 million (Q4 2025) and $158.87 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn | 124.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.16 Mn |
| Mar 31, 2026 | 129.68 Mn |
| Dec 31, 2025 | 138.28 Mn |
| Sep 30, 2025 | 158.87 Mn |
| Jun 30, 2025 | 167.91 Mn |
| Mar 31, 2025 | 186.47 Mn |
| Dec 31, 2024 | 198.65 Mn |
| Sep 30, 2024 | 220.40 Mn |
| Jun 30, 2024 | 178.14 Mn |
| Mar 31, 2024 | 65.91 Mn |
| Dec 31, 2023 | 68.79 Mn |
| Sep 30, 2023 | 67.34 Mn |
| Jun 30, 2023 | 70.78 Mn |
| Mar 31, 2023 | 72.98 Mn |
| Dec 31, 2022 | 74.18 Mn |
| Sep 30, 2022 | 86.52 Mn |
| Jun 30, 2022 | 90.95 Mn |
| Mar 31, 2022 | 96.92 Mn |
| Dec 31, 2021 | 123.93 Mn |
| Sep 30, 2021 | 141.81 Mn |
BridgeBio Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();